Navigation Links
Disrupting a destructive duo: U of T Mississauga researchers inhibit cancer proteins
Date:8/20/2009

A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.

Working with scientists at the University of Central Florida and the Princess Margaret Hospital, Professor Patrick Gunning of the Department of Chemical and Physical Sciences has created several molecules that inhibit Stat3, a protein that--in cancer cells--pairs with another copy of itself and goes haywire. The findings appear in the September issue of the journal ChemBioChem: A European Journal of Chemical Biology.

"The molecules we have created are particularly nice because they're showing selectivity against cancer cells but not against healthy cells," says senior author Gunning. "This molecule could be used in conjunction with typical chemotherapeutics, and it could mean that drugs will have less resistanceso you could use lower dosages and cause fewer side effects."

The Stat3 protein is involved in almost all cancers, and is known to contribute to the resistance of cancer cells to current drug therapies. "Most currently available therapeutics aim to induce cell death," says Gunning. "We wanted to make small molecules that could try and stop this protein."

In cancerous cells, Stat3 proteins bind together to work as a lethal pair, and inhibitors work to prevent this. This type of protein-protein interaction is notoriously difficult to counter. Gunning's team targeted binding "hotspots" on a known Stat3 inhibitor called S3I-201. They chemically altered the inhibitor to produce several new variants, which they then tested on Stat3.

In in vitro studies, some variants proved to be even more powerful than S3I-201, and showed activity against prostate, breast and acute myeloid leukemia cancer cell lines. "These are some of the most potent inhibitors in the literature so far for this particular protein," says Gunning. "In some cases, they were more than twice as effective as the existing inhibitor."

When the team used more complex cancer cell models, they found the inhibitors survived the passage across the cell membrane and still targeted the Stat3 cancer proteins inside. Gunning and his colleagues are working to make the new inhibitors even more effective, as well as more metabolically stable, meaning that they can survive the chemical defense mechanisms within the cell.


'/>"/>

Contact: Nicolle Wahl
nicolle.wahl@utoronto.ca
905-569-4656
University of Toronto
Source:Eurekalert

Related biology news :

1. Disrupting common parasites ability to talk to each other reduces infection
2. New genus of self-destructive palm found in Madagascar
3. Researchers boost production of biofuel that could replace gasoline
4. Researchers find genetic link between physical pain and social rejection
5. UTSA biology researchers demystify elusive war zone bacterium
6. UGA researchers propose model for disorders caused by improper transmission of chromosomes
7. Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer
8. NIH-funded researchers sequence exomes of 12 people
9. USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer
10. K-State lab gives researchers the tools to study porcine circovirus associated diseases
11. Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):
(Date:4/19/2017)... PA (PRWEB) , ... April 18, 2017 , ... ... to Halo Labs . The move comes after the company changed focus ... new market, our new brand and our new technology,” says CEO Robert Hart. ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of ... accessible to novices as well as experienced users, attendees will gain a better ... screening tests. , Hemostasis testing quality is determined by preanalytical variables which ...
(Date:4/19/2017)... 19, 2017 Veracyte, Inc. ... it will report its first quarter 2017 financial ... 2017. Following the announcement, Veracyte,s management will host a live ... discuss the company,s financial results and business progress. ... may be accessed by visiting Veracyte,s website at  http://investor.veracyte.com . ...
(Date:4/18/2017)... ... ... For a historic seventh consecutive year, Benchmark Research along with PMG Research ... of the top two Clinical Research Sites or Network. Benchmark Research has ... times previously, and first runner up the other three years. The only awards ceremony ...
Breaking Biology Technology: